Natural Capsules Limited Financial Ratios
NATCAPSUQ · Healthcare · Current price ₹159.5
P/E ratio
-8.0x
P/B ratio
1.1x
ROE
-7.7%
ROCE
-5.0%
Debt / Equity
0.52
Dividend yield
0.5%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -8.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -7.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -5.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.52 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Natural Capsules Limited's latest numbers.
Natural Capsules Limited profitability
Natural Capsules Limited generates a return on equity of -7.7% and a return on capital employed of -5.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.52 and a P/E of -8.0x, Natural Capsules Limited is moderately leveraged. Our overall business-quality score for the company is 3.9 / 10.
Understand the ratios
More on Natural Capsules Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.

